Teleflex Incorporated

Healthcare · Medical Instruments & Supplies

120.10$ -1.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Teleflex Incorporated (TFX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 570 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TFX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	456	514	488	529	535	595	587	610	610	642	614	653	648	681	631	567	628	711	634	713	700	762	642	705	687	758	711	743	746	774	738	750	764	795	701	781	913	569	548	570	2,601
Cost of Revenue	214	241	232	238	239	264	256	265	267	276	269	280	273	283	297	289	299	328	289	316	312	342	295	316	313	336	320	335	330	342	322	333	334	355	311	350	461	262	241	239	1,202
Gross Profit	242	273	256	290	295	331	331	345	343	366	345	373	376	398	334	278	329	384	345	398	388	420	346	389	374	422	391	408	416	431	416	416	430	440	389	431	452	307	307	332	1,398
Research & Development	15	16	18	20	21	25	26	26	26	28	27	28	28	31	27	29	29	34	30	33	32	36	36	37	38	43	41	39	38	36	37	41	39	45	36	39	57	49	44	45	195
Selling, General & Administrative	140	144	155	160	164	213	215	230	215	219	228	236	230	241	101	208	172	435	203	198	205	228	204	217	210	233	233	223	213	261	381	251	247	255	223	215	282	0.6	226	214	722
Total Operating Expenses	155	160	182	179	185	239	241	256	241	246	255	264	258	271	177	240	197	288	241	269	147	265	243	254	242	293	276	264	251	349	421	300	281	550	264	276	481	271	287	271	1,311
Operating Income	74	67	61	110	110	91	87	33	82	119	75	107	118	127	157	39	132	95	103	129	241	155	104	135	132	129	115	144	165	82	-4.8	117	149	-110	126	155	-30	36	20	60	87
Interest Expense	13	16	18	20	21	24	26	27	27	23	23	21	20	17	15	16	17	19	17	16	12	12	10	11	13	19	18	18	23	26	23	21	21	19	19	22	38	28	26	28	119
Pre-Tax Income	74	51	38	90	89	67	61	7.0	55	96	53	87	99	101	142	23	116	77	87	100	229	143	93	124	119	109	97	127	150	60	-26	97	131	-127	109	135	-439	-12	-3.8	45	-410
Income Tax Expense	7.5	-10	-2.7	12	10.0	110	6.2	9.6	-1.3	8.7	11	3.8	-130	-6.5	11	12	-1.0	0.0	12	16	30	16	16	18	17	31	20	16	12	29	-42	17	20	9.9	14	13	-30	-8.9	1.0	3.4	-34
Net Income	66	61	40	78	77	-43	56	-2.5	57	91	41	83	229	108	131	11	117	76	75	83	199	128	77	106	102	79	77	111	137	31	15	80	111	-137	95	123	-409	-714	-8.2	102	-1,029
EBITDA	116	97	88	147	148	140	140	86	134	173	129	167	171	173	213	96	189	153	164	176	300	214	162	192	189	188	176	205	230	150	63	187	220	-36	195	223	-323	16	-3.8	73	-238

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings